Merkle GmbH (unit responsible for manufacturing unpackaged products, primary and secondary packaging; unit responsible for batch release authorization)

The drug is used for the treatment of schizophrenia, manic episodes in bipolar disorders, as well as for the short-term treatment of severe aggression in patients with Alzheimer's dementia or in children and adolescents with behavioral disorders.

Dosage form: solution, oral

ATC: N05AX08